A. Staroselsky

649 total citations
21 papers, 501 citations indexed

About

A. Staroselsky is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, A. Staroselsky has authored 21 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in A. Staroselsky's work include Melanoma and MAPK Pathways (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A. Staroselsky is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A. Staroselsky collaborates with scholars based in Israel, United States and Australia. A. Staroselsky's co-authors include Joel Greif, Robert Radinsky, Yehuda Schwarz, Christoph Wilmanns, Zhongyun Dong, Isaiah J. Fidler, Dominic Fan, Isaiah J. Fidler, Sen Pathak and Sylvia Marmor and has published in prestigious journals such as Cancer, CHEST Journal and Annals of Oncology.

In The Last Decade

A. Staroselsky

20 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Staroselsky Israel 13 191 181 179 76 57 21 501
Peter C. Van Bodegom Netherlands 5 310 1.6× 315 1.7× 245 1.4× 148 1.9× 15 0.3× 9 625
Motoko Omura‐Minamisawa Japan 12 106 0.6× 126 0.7× 215 1.2× 102 1.3× 17 0.3× 18 418
Konrad Klinghammer Germany 14 181 0.9× 310 1.7× 235 1.3× 125 1.6× 34 0.6× 53 580
Antonella Facchinetti Italy 14 117 0.6× 240 1.3× 185 1.0× 172 2.3× 24 0.4× 40 546
Dusica Cvetković United States 13 114 0.6× 65 0.4× 210 1.2× 91 1.2× 15 0.3× 34 446
Heungnam Kim United States 10 85 0.4× 152 0.8× 274 1.5× 61 0.8× 40 0.7× 11 574
Saki Paul India 6 87 0.5× 236 1.3× 252 1.4× 172 2.3× 19 0.3× 6 475
Yasuhiro Terazaki Japan 12 112 0.6× 191 1.1× 182 1.0× 44 0.6× 15 0.3× 21 425
Gianni Capalbo Germany 11 59 0.3× 185 1.0× 245 1.4× 60 0.8× 14 0.2× 15 431
Marie‐Noëlle Guilly France 14 59 0.3× 139 0.8× 433 2.4× 96 1.3× 24 0.4× 26 709

Countries citing papers authored by A. Staroselsky

Since Specialization
Citations

This map shows the geographic impact of A. Staroselsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Staroselsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Staroselsky more than expected).

Fields of papers citing papers by A. Staroselsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Staroselsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Staroselsky. The network helps show where A. Staroselsky may publish in the future.

Co-authorship network of co-authors of A. Staroselsky

This figure shows the co-authorship network connecting the top 25 collaborators of A. Staroselsky. A scholar is included among the top collaborators of A. Staroselsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Staroselsky. A. Staroselsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merimsky, Ofer, A. Staroselsky, Moshe Inbar, et al.. (2001). Correlation between c-erbB-4 receptor expression and response to gemcitabine–cisplatin chemotherapy in non-small-cell lung cancer. Annals of Oncology. 12(8). 1127–1131. 19 indexed citations
2.
Merimsky, Ofer, Joel Greif, Y. Schwartz, et al.. (2001). Correlation between C-ERBB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small cell lung cancer. European Journal of Cancer. 37. S55–S55.
3.
Greif, Joel, Sylvia Marmor, Yehuda Schwarz, & A. Staroselsky. (1999). Percutaneous Core Needle Biopsy vs. Fine Needle Aspiration in Diagnosing Benign Lung Lesions. Acta Cytologica. 43(5). 756–760. 60 indexed citations
4.
Greif, Joel, et al.. (1999). Percutaneous core needle biopsy in the diagnosis of mediastinal tumors. Lung Cancer. 25(3). 169–173. 31 indexed citations
5.
Klein, O., A. Staroselsky, Monica Huszar, et al.. (1998). Biological behavior and cell properties of new AKR lymphoma malignancy variants. Tissue and Cell. 30(1). 95–103. 4 indexed citations
7.
Staroselsky, A., et al.. (1998). Additional Information From Percutaneous Cutting Needle Biopsy Following Fine-Needle Aspiration in the Diagnosis of Chest Lesions. CHEST Journal. 113(6). 1522–1525. 30 indexed citations
9.
Donin, Natalie, et al.. (1997). Comparison of Growth Rate of Two B16 Melanomas Differing in Metastatic Potential in Young Versus Middle-Aged Mice. Cancer Investigation. 15(5). 416–421. 15 indexed citations
10.
Kaer, Luc Van, Semyon A. Risin, A. Staroselsky, et al.. (1996). Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones. Clinical & Experimental Metastasis. 14(2). 95–106. 22 indexed citations
11.
Klein, O., Naphtali Savion, A. Staroselsky, et al.. (1996). Metastasis-related cell functions in primary and metastatic tumor cells of AKR lymphoma. Cancer Letters. 101(2). 219–225. 2 indexed citations
12.
Fidler, Isaiah J., Christoph Wilmanns, A. Staroselsky, et al.. (1994). Modulation of tumor cell response to chemotherapy by the organ environment. Cancer and Metastasis Reviews. 13(2). 209–222. 132 indexed citations
13.
Savion, Naphtali, et al.. (1992). Cellular Functions Related to Metastasis Differing between Low- and High-Malignancy Variants of AKR Lymphoma. Pathobiology. 60(3). 157–162. 4 indexed citations
14.
Staroselsky, A., Robert Radinsky, Isaiah J. Fidler, et al.. (1992). The use of molecular genetic markers to demonstrate the effect of organ environment on clonal dominance in a human renal‐cell carcinoma grown in nude mice. International Journal of Cancer. 51(1). 130–138. 24 indexed citations
15.
Radinsky, Robert, et al.. (1992). Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.. PubMed. 52(20). 5808–14. 35 indexed citations
16.
Pathak, Sen, A. Staroselsky, & Isaiah J. Fidler. (1991). Specific chromosomal defects associated with metastatic potential in K-1735 melanoma clones. Cancer Genetics and Cytogenetics. 56(2). 209–221. 12 indexed citations
17.
Staroselsky, A., Sen Pathak, & Isaiah J. Fidler. (1990). Changes in clonal composition during in vivo growth of mixed subpopulations derived from the murine K-1735 melanoma.. PubMed. 10(2A). 291–6. 14 indexed citations
18.
Staroselsky, A., Di Fan, C A O'Brian, et al.. (1990). Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin.. PubMed. 50(24). 7775–80. 28 indexed citations
19.
Friedman, Joseph H., H. Levinsky, D. Allalouf, & A. Staroselsky. (1988). Sialic acid content in mouse myeloma cells and derived B-cell hybridomas with different metastic potentials. Cancer Letters. 43(1-2). 79–84. 3 indexed citations
20.
Staroselsky, A., et al.. (1986). Concanavalin A receptor capping in mouse myeloma and hybridoma. Cell Biology International Reports. 10(2). 121–129. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026